KEMBAR78
Recombinant vaccine | PPTX
Recombinant vaccine
neethu asokan
• A vaccine is a biological preparation that
improves immunity to a particular disease.
(http://www.who.int/)
• Injection of a killed microbe in order to stimulate
the immune system against the microbe, thereby
preventing disease.
(http://www.medicinenet.com/)
neethu asokan
• The term ''vaccine'' was derived from the
Edward Jenner's 1796 use of the term ''cow
pox'' (Latin ''variolĂŚ vaccinĂŚ'', adapted from
the Latin ''vaccÄŤn-us'', from ''vacca'' cow).
• He was the pioneer of using cow pox
vaccines to prevent small pox infections.
neethu asokan
• Live, attenuated vaccines
• Inactivated vaccine
• Subunit vaccine
• Toxoid vaccine
• Conjugated vaccine
• DNA vaccine
• Recombinant vector vaccines
neethu asokan
• Vaccine antigens may also be produced
by genetic engineering technology. These
products are sometimes referred to as
recombinant vaccines.
neethu asokan
• The FDA licensed Merck’s Recombivax HB. This
hepatitis B vaccine was the first human vaccine
produced by recombinant DNA methods in 1981.
• In 1986, research resulted in a second generation of
genetically engineered (or DNA recombinant)
hepatitis B vaccines.
neethu asokan
• Subunit vaccines:
These are the components of the pathogenic organisms. Subunit
vaccines include protein , peptides and DNA.
• Attenuated recombinant vaccines:
These are the genetically modified pathogenic organisms that
are made non-pathogenic and used as vaccines.
• Vector recombinant vaccines:
These are the genetically modified viral vectors that can be used
as vaccines against certain pathogens.
neethu asokan
• Subunit recombinant vaccine are the components (proteins,
peptides, DNA) of the pathogenic organisms.
• Advantages :
This vaccines include their purity in preparation, stability and
safe use.
• Disadvantages:
High cost factor and possible alteration in native
conformation.
Eg: Hepatitis B, HSV, BCG.neethu asokan
• Subunit vaccines can be broadly grouped into two kinds:
(i) Recombinant protein vaccines: This is based on production
of recombinant DNA which is expressed to release the specific
protein used in vaccine preparation
(ii) DNA vaccines: Here the gene encoding for immunogenic
protein is isolated and used to produce recombinant DNA
which acts as vaccine to be injected into the individual.
neethu asokan
• Hepatitis B is a widespread disease in man.
• It primarily affects liver causing chronic
hepatitis, cirrhosis and liver cancer.
neethu asokan
• The gene encoding for hepatitis B surface antigen
(HBsAg) has been identified.
• The HBsAg vaccine as a subunit vaccine, is produced
by cloning HBsAg gene in yeast cells (Sacchromyces
cerevisiae).
neethu asokan
neethu asokan
• The immune response of the body is stimulated by a
DNA molecule.
• The DNA vaccine, gene encoding an antigenic protein.
• Inserted onto a plasmid and incorporated to the target
animal cell of the host.
• Antigenic proteins are developed the humoral
immunity or cellular immunity
neethu asokan
DNA vaccine and its mechanism
neethu asokan
Advantages:
• DNA vaccine are very specific in producing target protein.
• Higher immune responds.
• more stable in various temperature.
Disadvantages:
• The fact of the DNA vaccine in the host cells is not yet clear.
• There also exists a danger of cancer due to DNA vaccine
• The post translational modified gene produced the antigen
may not be the same as the native antigen.
neethu asokan
• Genetically engineer the organism and use them as live
vaccines.
The production of vaccine based on the two types:
• Detection or modification of the virulence genes of the
pathogenic organisms.
• Genetically manipulated non pathogenic organisms to carry
and express antigen determinates from pathogenic organisms.
Eg: Cholera, Salmonella spp, Leishmania spp
neethu asokan
• Cholera is an intestinal disease.
• It is an characterized by diarrhea, dehydration,
abdominal pain and fever.
• It is an caused by a vibrio cholerae.
neethu asokan
• The genetically engineered V. cholerae is a good
attenuated vaccine.
• Cholera vaccine is composed of phenol killed V.
cholera.
• The genetically engineered V. cholerae cells with
deleted A1 peptide DNA sequence are quite
stable. So they can not produce enterotoxin.
neethu asokan
Advantages:
• This type of vaccines is that the native conformation of
the immunogenic determination is preserved, hence
the immune response is substantially high.
Disadvantages:
• There are caused some side effects.
neethu asokan
Development of new
strain of V. cholerae
as a attenuated
recombinant vaccine.
neethu asokan
• Vectors can be genetically modified and employed as
vaccines against pathogens.
• Vaccinia virus is used to the vector vaccine.
• The vaccinia virus is the possibility of vaccinating
individuals against different diseases simultaneously.
• The advantage with vector vaccine is that it
stimulates B-lymphocytes and T-lymphocytes.
neethu asokan
• Vaccinia viruse processed to release their DNAs.
• Then genes from hepatitis B virus, herpes simplex virus
and influenza virus are inserted into vaccinia virus
genome.
• This injected to E.coli and increasing their number and
produce plasmid insertion vectors.
neethu asokan
• The plasmid and vaccinia virus injected into the
animal cell.
• The plasmid insertion vector incorporates its genes
into vaccinia virus genome at a place encodes for the
enzyme thymidine kinase (TK).
• This replicate the vector recombinant vaccine and
purified the vaccine to use.
neethu asokan
neethu asokan
Advantages:
• Antigens that closely resemble natural antigen can be
produced.
• Stimulate the T- lymphocytes and B- lymphocytes.
Disadvantages:
• Important limitation is the unknown risk of using in humans.
• Using this, may be serious complication in immuno
suppressed individuals as AIDS patients.neethu asokan
• FanC subunit of E. coli expressed in soybeans as possible oral vaccine for
E. coli induced diarrhea in cattle, sheep and goats.
• Capripox vaccine used as vector to protect against rinderpest and peste-
des-petits ruminants.
• Human adenovirus used as vector to deliver hemagglutinin and
nucleoproteins from swine influenza virus.
• Fowlpox virus vectored vaccines for avian influenza, Newcastle disease,
avian encephalomyelitis, laryngotracheitis, and Mycoplasma gallisepitum.
• Canada licensed first DNA vaccine for infectious haemopoetic necrosis
virus in salmon.
• Canarypox-vectored feline vaccines for leukemia and feline rabies.neethu asokan
Resent recombinant vaccines
• Classical swine fever virus (CSFV) is a live
attenuated vaccine.
• Bacterial vaccines - Bacille Calmette-Gurein
(BCG), Listeria monocytogenes, salmonellae
and shigellae vaccine vectors.
• Flu vaccine for influenza viruses.
neethu asokan
Reference
• U. Satyanarayana – Biotechnology.
• www.who.in
• www.medicinenet.com
• www.vaccines.gov
• www.biotechnology forums.com
• www.medscape.com
neethu asokan
neethu asokan

Recombinant vaccine

  • 1.
  • 2.
    • A vaccineis a biological preparation that improves immunity to a particular disease. (http://www.who.int/) • Injection of a killed microbe in order to stimulate the immune system against the microbe, thereby preventing disease. (http://www.medicinenet.com/) neethu asokan
  • 3.
    • The term''vaccine'' was derived from the Edward Jenner's 1796 use of the term ''cow pox'' (Latin ''variolæ vaccinæ'', adapted from the Latin ''vaccīn-us'', from ''vacca'' cow). • He was the pioneer of using cow pox vaccines to prevent small pox infections. neethu asokan
  • 4.
    • Live, attenuatedvaccines • Inactivated vaccine • Subunit vaccine • Toxoid vaccine • Conjugated vaccine • DNA vaccine • Recombinant vector vaccines neethu asokan
  • 5.
    • Vaccine antigensmay also be produced by genetic engineering technology. These products are sometimes referred to as recombinant vaccines. neethu asokan
  • 6.
    • The FDAlicensed Merck’s Recombivax HB. This hepatitis B vaccine was the first human vaccine produced by recombinant DNA methods in 1981. • In 1986, research resulted in a second generation of genetically engineered (or DNA recombinant) hepatitis B vaccines. neethu asokan
  • 7.
    • Subunit vaccines: Theseare the components of the pathogenic organisms. Subunit vaccines include protein , peptides and DNA. • Attenuated recombinant vaccines: These are the genetically modified pathogenic organisms that are made non-pathogenic and used as vaccines. • Vector recombinant vaccines: These are the genetically modified viral vectors that can be used as vaccines against certain pathogens. neethu asokan
  • 8.
    • Subunit recombinantvaccine are the components (proteins, peptides, DNA) of the pathogenic organisms. • Advantages : This vaccines include their purity in preparation, stability and safe use. • Disadvantages: High cost factor and possible alteration in native conformation. Eg: Hepatitis B, HSV, BCG.neethu asokan
  • 9.
    • Subunit vaccinescan be broadly grouped into two kinds: (i) Recombinant protein vaccines: This is based on production of recombinant DNA which is expressed to release the specific protein used in vaccine preparation (ii) DNA vaccines: Here the gene encoding for immunogenic protein is isolated and used to produce recombinant DNA which acts as vaccine to be injected into the individual. neethu asokan
  • 10.
    • Hepatitis Bis a widespread disease in man. • It primarily affects liver causing chronic hepatitis, cirrhosis and liver cancer. neethu asokan
  • 11.
    • The geneencoding for hepatitis B surface antigen (HBsAg) has been identified. • The HBsAg vaccine as a subunit vaccine, is produced by cloning HBsAg gene in yeast cells (Sacchromyces cerevisiae). neethu asokan
  • 12.
  • 13.
    • The immuneresponse of the body is stimulated by a DNA molecule. • The DNA vaccine, gene encoding an antigenic protein. • Inserted onto a plasmid and incorporated to the target animal cell of the host. • Antigenic proteins are developed the humoral immunity or cellular immunity neethu asokan
  • 14.
    DNA vaccine andits mechanism neethu asokan
  • 15.
    Advantages: • DNA vaccineare very specific in producing target protein. • Higher immune responds. • more stable in various temperature. Disadvantages: • The fact of the DNA vaccine in the host cells is not yet clear. • There also exists a danger of cancer due to DNA vaccine • The post translational modified gene produced the antigen may not be the same as the native antigen. neethu asokan
  • 16.
    • Genetically engineerthe organism and use them as live vaccines. The production of vaccine based on the two types: • Detection or modification of the virulence genes of the pathogenic organisms. • Genetically manipulated non pathogenic organisms to carry and express antigen determinates from pathogenic organisms. Eg: Cholera, Salmonella spp, Leishmania spp neethu asokan
  • 17.
    • Cholera isan intestinal disease. • It is an characterized by diarrhea, dehydration, abdominal pain and fever. • It is an caused by a vibrio cholerae. neethu asokan
  • 18.
    • The geneticallyengineered V. cholerae is a good attenuated vaccine. • Cholera vaccine is composed of phenol killed V. cholera. • The genetically engineered V. cholerae cells with deleted A1 peptide DNA sequence are quite stable. So they can not produce enterotoxin. neethu asokan
  • 19.
    Advantages: • This typeof vaccines is that the native conformation of the immunogenic determination is preserved, hence the immune response is substantially high. Disadvantages: • There are caused some side effects. neethu asokan
  • 20.
    Development of new strainof V. cholerae as a attenuated recombinant vaccine. neethu asokan
  • 21.
    • Vectors canbe genetically modified and employed as vaccines against pathogens. • Vaccinia virus is used to the vector vaccine. • The vaccinia virus is the possibility of vaccinating individuals against different diseases simultaneously. • The advantage with vector vaccine is that it stimulates B-lymphocytes and T-lymphocytes. neethu asokan
  • 22.
    • Vaccinia viruseprocessed to release their DNAs. • Then genes from hepatitis B virus, herpes simplex virus and influenza virus are inserted into vaccinia virus genome. • This injected to E.coli and increasing their number and produce plasmid insertion vectors. neethu asokan
  • 23.
    • The plasmidand vaccinia virus injected into the animal cell. • The plasmid insertion vector incorporates its genes into vaccinia virus genome at a place encodes for the enzyme thymidine kinase (TK). • This replicate the vector recombinant vaccine and purified the vaccine to use. neethu asokan
  • 24.
  • 25.
    Advantages: • Antigens thatclosely resemble natural antigen can be produced. • Stimulate the T- lymphocytes and B- lymphocytes. Disadvantages: • Important limitation is the unknown risk of using in humans. • Using this, may be serious complication in immuno suppressed individuals as AIDS patients.neethu asokan
  • 26.
    • FanC subunitof E. coli expressed in soybeans as possible oral vaccine for E. coli induced diarrhea in cattle, sheep and goats. • Capripox vaccine used as vector to protect against rinderpest and peste- des-petits ruminants. • Human adenovirus used as vector to deliver hemagglutinin and nucleoproteins from swine influenza virus. • Fowlpox virus vectored vaccines for avian influenza, Newcastle disease, avian encephalomyelitis, laryngotracheitis, and Mycoplasma gallisepitum. • Canada licensed first DNA vaccine for infectious haemopoetic necrosis virus in salmon. • Canarypox-vectored feline vaccines for leukemia and feline rabies.neethu asokan
  • 27.
    Resent recombinant vaccines •Classical swine fever virus (CSFV) is a live attenuated vaccine. • Bacterial vaccines - Bacille Calmette-Gurein (BCG), Listeria monocytogenes, salmonellae and shigellae vaccine vectors. • Flu vaccine for influenza viruses. neethu asokan
  • 28.
    Reference • U. Satyanarayana– Biotechnology. • www.who.in • www.medicinenet.com • www.vaccines.gov • www.biotechnology forums.com • www.medscape.com neethu asokan
  • 29.